GLORY HEALTH (02329) Reports Interim Results with Attributable Loss of RMB225 Million, Up 283.88% Year-on-Year
Stock News
Aug 29, 2025
GLORY HEALTH (02329) announced its interim results for the six months ended June 30, 2025. The group recorded revenue of RMB324 million, representing a year-on-year decrease of 67.17%. The loss attributable to owners of the company reached RMB225 million, surging 283.88% compared to the same period last year. Basic loss per share stood at 5.07 cents.
According to the announcement, property development revenue for the six months ended June 30, 2025 amounted to RMB183 million, down 76.9% from the corresponding period last year. The decline in revenue during the reporting period was primarily attributed to reduced completion and delivery area in the property development segment, as well as decreased sales.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.